Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D treatment effect on retinal nerve fiber loss after optic neuritis
2010-018498-39Phase 3Active
- Sponsor
- Erasmus MC
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in optic neuritis (ON) comparing High-dose cholecalciferol with Placebo (2 arms). Primary endpoint: Retinal nerve fiber layer thickness. Started Mar 2010; status: active.
02
Drugs
vitamin d
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on 2010-018498-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018498-39.